The Duke Sarcoma Center is part of the Sarcoma Alliance for Research through Collaboration (SARC), a group of leading U.S. sarcoma centers dedicated to improving the care of sarcoma patients through research and clinical trials. As a result, we offer a level of expertise and sub-specialization that very few centers in the country can offer.
Our team of specialists uses a patient-centric approach to diagnose and treat bone and soft-tissue sarcomas. We provide unsurpassed clinical care, personalized treatment to more than 2,000 adult and pediatric patients who are actively being treated or who are sarcoma cancer survivors. Each year, more than 900 new adult and pediatric patients are seen at the Duke Cancer Center in Durham and Duke Children’s Hospital and Health Center. Research shows that patients experience better survival and quality of life outcomes when they receive their care at a sub-specialized cancer treatment center, like the Duke Sarcoma Center.
Our team includes adult and pediatric medical, surgical, and radiation oncologists, and sub-specialized pathologists. The team meets at a weekly multidisciplinary tumor board to review imaging and pathology. Consensus is built around creating the best treatment plan for each individual patient. Our team uses sophisticated technologies to diagnose and stage sarcomas. They recommend the best treatment options for the individual patient to remove the mass while preserving healthy tissue and bone.
This collaborative approach is important because tumors that form in the bones and tumors that occur in soft tissue sarcoma are challenging to diagnose and cure. There are more than 50 types of sarcomas and more than 100 different subtypes that can affect people of any age.
These rare and complex tumors can be benign or metastatic. Our experts in metastatic bone cancer work closely with patients to slow the spread of cancer, relieve symptoms, and maximize mobility.
We also conduct basic scientific and clinical research. Our scientists are leading the way in the research of sarcoma and studying the cancer in children as well as adults.